IFNG and neoplasm: Since IFN-γ processing can enhance tumor immunity by increasing T-cell and macrophage activity (65, 66), tumor cells resistant to IFN-γ may not necessarily be caused by their own drug resistance, but may be caused by the tumor promoting immune escape or creating an immunosuppressive microenvironment.